Mitsubishi UFJ Trust & Banking Corp Cuts Position in GE HealthCare Technologies Inc. $GEHC

Mitsubishi UFJ Trust & Banking Corp decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.0% during the 4th quarter, Holdings Channel reports. The fund owned 221,684 shares of the company’s stock after selling 9,283 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in GE HealthCare Technologies were worth $18,183,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the company. Thoma Capital Management LLC lifted its position in shares of GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares during the last quarter. Klingman & Associates LLC raised its stake in GE HealthCare Technologies by 4.0% in the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after buying an additional 139 shares in the last quarter. Colonial Trust Advisors raised its stake in GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after buying an additional 139 shares in the last quarter. Norinchukin Bank The lifted its holdings in GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after buying an additional 149 shares during the last quarter. Finally, Childress Capital Advisors LLC boosted its position in shares of GE HealthCare Technologies by 5.4% during the 3rd quarter. Childress Capital Advisors LLC now owns 2,979 shares of the company’s stock worth $224,000 after acquiring an additional 152 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In related news, CEO Peter J. Arduini purchased 4,169 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was acquired at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the purchase, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Frank R. Jimenez purchased 1,750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were bought at an average cost of $60.45 per share, with a total value of $105,787.50. Following the completion of the acquisition, the insider owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.36% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on GEHC shares. Evercore set a $80.00 target price on GE HealthCare Technologies in a research report on Thursday. Bank of America increased their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Oppenheimer restated an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a report on Thursday. Finally, Piper Sandler dropped their target price on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating on the stock in a research report on Friday, April 17th. Eight investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $80.67.

GE HealthCare Technologies Stock Up 2.3%

GEHC stock opened at $60.84 on Friday. The company has a market cap of $27.76 billion, a price-to-earnings ratio of 14.56, a price-to-earnings-growth ratio of 1.34 and a beta of 1.17. The company has a fifty day moving average price of $73.28 and a 200 day moving average price of $77.52. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter in the prior year, the firm posted $1.01 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.9 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.35%.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insiders bought shares: CEO Peter Arduini purchased 4,169 shares (~$59.92 avg; SEC filing), and director Frank R. Jimenez bought 1,750 shares (~$60.45 avg). Insider purchases are viewed as management expressing confidence in the company’s outlook. Arduini Form 4 Jimenez Form 4
• Neutral Sentiment: Q1 results were mixed: revenue beat estimates ($5.13B vs ~$5.03B) but EPS missed ($0.99 vs $1.07 consensus); revenue rose Y/Y but margins compressed. The topline strength helps the growth story, while margin pressure explains near‑term caution. Q1 Press Release
• Neutral Sentiment: Operational updates: GEHC is combining Imaging and Advanced Visualization Solutions into Advanced Imaging Solutions and announced executive changes intended to improve execution — a strategic move but one that may take time to show benefit. Operational Updates
• Negative Sentiment: Guidance cut and margin pressure: Management trimmed FY26 EPS guidance to $4.80–5.00 (below consensus ~5.05) and cited inflation, higher chip/oil/freight costs and supply pressures — the primary driver of the recent sell‑off. Reuters: Guidance Cut
• Negative Sentiment: Analyst downgrades/price‑target cuts: JPMorgan and Citigroup cut targets from $80 to $65 and set neutral ratings, contributing to downward pressure; several other firms trimmed targets or adjusted ratings. These moves signal lowered near‑term expectations from buyside/sellside. Benzinga coverage
• Negative Sentiment: Investor litigation inquiry: Law firm Johnson Fistel is investigating potential claims against GEHC executives, adding legal/regulatory risk and potential headline volatility. GlobeNewswire: Litigation Notice

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.